Medicare Drug Prices and the Deficit

被引：1
|
作者：
Frank, Richard G. [1 ]
机构：
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 18期
关键词：
D O I：
10.1056/NEJMp1109926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1657 / 1659
页数：3
相关论文
共 50 条
  • [21] MarketWatch - The impact of a national prescription drug formulary on prices, market share, and spending: Lessons for Medicare?
    Huskamp, HA
    Epstein, AM
    Blumenthal, D
    HEALTH AFFAIRS, 2003, 22 (03) : 149 - 158
  • [22] Will competitive bidding decrease medicare prices?
    Katzman, Brett
    McGeary, Kerry Anne
    SOUTHERN ECONOMIC JOURNAL, 2008, 74 (03) : 839 - 856
  • [23] The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?
    Johnson, Micah
    Kishore, Sanjay
    Nayak, Rahul K.
    Dusetzina, Stacie B.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (06) : 577 - 581
  • [24] The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?
    Micah Johnson
    Sanjay Kishore
    Rahul K. Nayak
    Stacie B. Dusetzina
    Current Cardiology Reports, 2023, 25 : 577 - 581
  • [25] Why Medicare Advantage Plans Pay Hospitals Traditional Medicare Prices
    Berenson, Robert A.
    Sunshine, Jonathan H.
    Helms, David
    Lawton, Emily
    HEALTH AFFAIRS, 2015, 34 (08) : 1289 - 1295
  • [26] DEFICIT REDUCTION ACT FOCUSES ON MEDICARE
    MICKEL, C
    HOSPITALS, 1984, 58 (15): : 32 - 32
  • [27] Medicare could save up to $16bn if allowed to negotiate drug prices, paper finds
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [28] Tying Medicare Part B Drug Prices to International Reference Pricing Will Devastate R&D
    Duane Schulthess
    Daniel Gassull
    Steven Maisel
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 746 - 751
  • [29] Tying Medicare Part B Drug Prices to International Reference Pricing Will Devastate R&D
    Schulthess, Duane
    Gassull, Daniel
    Maisel, Steven
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (06) : 746 - 751
  • [30] DRUG PRICES
    COLEBROOK, PV
    ECONOMIST, 1964, 212 (01): : 5 - 5
12345